Search Results 1031-1040 of 18997 for Neutrophil

1. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection - Mayo Clinic

   An absolute neutrophil count of <1000 cells/μL during Screening. Known or suspected current (< 90 days) illicit drug use. Note: marijuana use is allowed ...

2. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC - Mayo Clinic

   Absolute neutrophil count* ≥ 1.0 x 10^9 (1000 per mm^3); Platelet count* ≥ 100 x 10^9 (100,000 per mm^3). Hepatic. Total bilirubin ≤ 1.5 x ULN in the ...

3. FT516 in Subjects With Advanced Hematologic Malignancies - Mayo Clinic

   Neutrophils and platelets: AML: No count restrictions for neutrophils or platelets;; Lymphoma: Neutrophils 1.5 × upper limit normal (ULN), not applicable for ...

4. Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors - Mayo Clinic

   Absolute neutrophil count ≥ 1500/mm^3. Platelets ≥ 100,000/mm^3. Hemoglobin ≥ 9 g/dL. Potassium ≥ lower limit of normal (LLN) range for the institution ...

5. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Absolute neutrophil count (ANC) ³1500/mm3;; Untransfused Platelet count ³75000/mm3;; Hemoglobin ≥8.0 g/dL;; Total bilirubin ≤ 1.5 x ULN;; ALT and AST ≤ 2.5 x ...

6. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

   earlier. 7. Has adequate hematologic function, including: - White blood cell count ≥ 2.0 × 10^9/L - Absolute neutrophil count ≥ 1.5 × 10^9/L - Absolute ...

7. Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1000/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) and aspartate ...

8. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

   - Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (1500/uL) without granulocyte colony-stimulating factor support (obtained =< 28 days prior to ...

9. Find cancer clinical trials - Mayo Clinic

   ... neutrophil cytoplasmic antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. A Study of HFB200301 in Adult ...

10. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

    Absolute neutrophil count ≥ 1,500/ microliter (mcL); Hemoglobin ≥10 g/dL; Platelets ≥ 100,000/ mcL; International normalized ratio (INR) ≤ 1.2 X Upper ...